Dr. Ward is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-3250- Is this information wrong?
Summary
- Dr. Ward is a clinical scientist with exclusive focus on the management of prostate and testicular cancers. He is recognized as one of the early thought leaders in the prostate cancer imaging and focal therapy. His contributions laid the ground work that has helped this approach gain recognition as an acceptable therapeutic strategy for select patients with prostate cancer. He helped develop ablative techniques using variety of energy and imaging techniques including the early studies of interstitial laser ablation, focal cryotherapy and high-intensity focused ultrasound; the later work leading to the FDA US approval. He is equally involved in development of urine and blood bio-markers of prostate cancer and now image guided targeted prostate biopsy. As a busy clinician, Dr. Ward not only pioneered the MD Anderson Cancer Center Prostate cancer imaging and focal therapy program while performing 200+ robotic assisted prostatectomies a year, but he also developed the MD Anderson technique of robotic retroperitoneal lymph node dissection and has now expanded this surgery into both the post-chemotherapy setting and as primary treatment for metastatic seminoma.
A native of Pittsburgh, Pennsylvania, Dr. Ward is a Graduate of the University of Notre Dame and Georgetown Medical School. He received his urologic oncology training at the Mayo Clinic, Rochester, Minnesota before completing a career with the US Navy. He joined the faculty at M.D. Anderson Cancer Center in 2006.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Minimally Invasive Urologic Surgery, 2001 - 2003
Naval Medical Center (San Diego)Residency, Urology, 1993 - 1998- Naval Medical Center (San Diego)Internship, Transitional Year, 1991 - 1992
Georgetown University School of MedicineClass of 1991
Certifications & Licensure
FL State Medical License 2021 - Present
CA State Medical License 1992 - Present
WA State Medical License 2023 - 2025
AZ State Medical License 2023 - 2025
MS State Medical License 2023 - 2024
OK State Medical License 2020 - 2024
TN State Medical License 2023 - 2024- American Board of Urology Urology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Prostate Conformal Cryotherapy Start of enrollment: 2009 Apr 06
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer Start of enrollment: 2011 Jan 27
- Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance. Start of enrollment: 2011 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy.Wang, L., Sanders, J., Poenisch, F., Swanson, D., Sahoo, N., Zhu, X., Ma, J., Kudchadker, R., Ward, J., Lee, S., Choi, S., Nguyen, Q., Mayo, L., Shah, S., Frank, S.> ;Cancers. 2024 Jan 31
- The association of body mass index with tumor aggression among men undergoing radical prostatectomy.Justin R Gregg, Resa Magill, Andrew M Fang, Brian F Chapin, John W Davis, Mehrad Adibi, Lisly Chéry, John Papadopoulos, Curtis Pettaway, Louis Pisters, John F Ward, An...> ;Urologic Oncology. 2024 Apr 1
- 1 citationsPrimary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.Sriram Deivasigamani, Srinath Kotamarti, Ardeshir R Rastinehad, Rafael Sanchez Salas, J J M C H de la Rosette, Herbert Lepor, Peter Pinto, Hashim U Ahmed, Inderbir Gil...> ;European Urology. 2023 Dec 1
- Join now to see all
Other
- Initial management of regionally localized intermediate and high risk prostate cancerWard JF, Davis B, Vogelzang N
http://www.uptodate.com/contents/initial-management-of-regionally-localized-intermediate-and-high-ri
UpToDate, Wolters Kluwer Health - 2013-02-25 - Pathologic stage T3 and margin positive prostate cancerWard JF, Davis B, Vogelzang N
http://www.uptodate.com/contents/pathologic-stage-t3-and-margin-positive-prostate-cancer
UpToDate, Wolters Kluwer Health - 2013-01-03
Press Mentions
Focal Therapy for Prostate Ca: Ready for Prime Time?October 5th, 2018
Professional Memberships
- Member
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
